Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15744 | 695 | 38.2 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
385 | 3 | MICROGLIA//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM | 31368 |
2761 | 2 | CANAVAN DISEASE//N ACETYLASPARTYLGLUTAMATE//N ACETYLASPARTATE | 3180 |
15744 | 1 | CANAVAN DISEASE//N ACETYLASPARTYLGLUTAMATE//ASPARTOACYLASE | 695 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANAVAN DISEASE | authKW | 3882168 | 16% | 82% | 108 |
2 | N ACETYLASPARTYLGLUTAMATE | authKW | 2506060 | 11% | 77% | 74 |
3 | ASPARTOACYLASE | authKW | 2130475 | 8% | 85% | 57 |
4 | NAAG | authKW | 1533898 | 6% | 78% | 45 |
5 | N ACETYLASPARTIC ACID | authKW | 689573 | 3% | 83% | 19 |
6 | N ACETYLASPARTATE | authKW | 569539 | 13% | 14% | 93 |
7 | N ACETYLASPARTYLGLUTAMATE NAAG | authKW | 421766 | 2% | 80% | 12 |
8 | GLUTAMATE CARBOXYPEPTIDASE II | authKW | 380977 | 3% | 38% | 23 |
9 | MOLECULAR WATER PUMPS | authKW | 355867 | 1% | 90% | 9 |
10 | N ACETYL L ASPARTATE | authKW | 331185 | 2% | 54% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 5263 | 51% | 0% | 351 |
2 | Biochemistry & Molecular Biology | 649 | 28% | 0% | 196 |
3 | Clinical Neurology | 578 | 14% | 0% | 96 |
4 | Medicine, Research & Experimental | 451 | 11% | 0% | 73 |
5 | Genetics & Heredity | 232 | 9% | 0% | 62 |
6 | Pediatrics | 142 | 6% | 0% | 41 |
7 | Pharmacology & Pharmacy | 116 | 10% | 0% | 70 |
8 | Endocrinology & Metabolism | 102 | 6% | 0% | 41 |
9 | Biochemical Research Methods | 22 | 3% | 0% | 20 |
10 | Psychiatry | 16 | 3% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUT THER Y NEUROPHARMACOL | 100410 | 1% | 29% | 8 |
2 | ANAT PHYSIOL GENET | 99473 | 5% | 7% | 32 |
3 | NSF BIOPHON SCI TECHNOL | 87869 | 0% | 100% | 2 |
4 | PEDIAT HUMAN BIOL CHEM GENET | 58578 | 0% | 67% | 2 |
5 | HUMAN DEV CONSUMER SCI | 56484 | 0% | 43% | 3 |
6 | NEUROTRANSLAT DRUG DISCOVERY PROGRAM | 54068 | 1% | 31% | 4 |
7 | BIOSCI FRE 3005CNRS BIOCHIM BIOL NUTRSERV | 43934 | 0% | 100% | 1 |
8 | BRAZILIAN NEUROSCI NEUROTECHNOL | 43934 | 0% | 100% | 1 |
9 | CHAIR NERVOUSE DIS REGENERAT MED | 43934 | 0% | 100% | 1 |
10 | CIENCIAS SECC GENET EVOLUT | 43934 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROCHEMISTRY | 9158 | 9% | 0% | 66 |
2 | JOURNAL OF INHERITED METABOLIC DISEASE | 6531 | 4% | 1% | 26 |
3 | NEUROPEDIATRICS | 1739 | 1% | 0% | 9 |
4 | BRAIN RESEARCH | 1435 | 6% | 0% | 40 |
5 | METABOLIC BRAIN DISEASE | 1104 | 1% | 0% | 6 |
6 | JOURNAL OF MOLECULAR NEUROSCIENCE | 1022 | 1% | 0% | 8 |
7 | NEUROCHEMICAL RESEARCH | 999 | 2% | 0% | 13 |
8 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 929 | 3% | 0% | 19 |
9 | NEUROCHEMISTRY INTERNATIONAL | 653 | 1% | 0% | 9 |
10 | NMR IN BIOMEDICINE | 480 | 1% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANAVAN DISEASE | 3882168 | 16% | 82% | 108 | Search CANAVAN+DISEASE | Search CANAVAN+DISEASE |
2 | N ACETYLASPARTYLGLUTAMATE | 2506060 | 11% | 77% | 74 | Search N+ACETYLASPARTYLGLUTAMATE | Search N+ACETYLASPARTYLGLUTAMATE |
3 | ASPARTOACYLASE | 2130475 | 8% | 85% | 57 | Search ASPARTOACYLASE | Search ASPARTOACYLASE |
4 | NAAG | 1533898 | 6% | 78% | 45 | Search NAAG | Search NAAG |
5 | N ACETYLASPARTIC ACID | 689573 | 3% | 83% | 19 | Search N+ACETYLASPARTIC+ACID | Search N+ACETYLASPARTIC+ACID |
6 | N ACETYLASPARTATE | 569539 | 13% | 14% | 93 | Search N+ACETYLASPARTATE | Search N+ACETYLASPARTATE |
7 | N ACETYLASPARTYLGLUTAMATE NAAG | 421766 | 2% | 80% | 12 | Search N+ACETYLASPARTYLGLUTAMATE+NAAG | Search N+ACETYLASPARTYLGLUTAMATE+NAAG |
8 | GLUTAMATE CARBOXYPEPTIDASE II | 380977 | 3% | 38% | 23 | Search GLUTAMATE+CARBOXYPEPTIDASE+II | Search GLUTAMATE+CARBOXYPEPTIDASE+II |
9 | MOLECULAR WATER PUMPS | 355867 | 1% | 90% | 9 | Search MOLECULAR+WATER+PUMPS | Search MOLECULAR+WATER+PUMPS |
10 | N ACETYL L ASPARTATE | 331185 | 2% | 54% | 14 | Search N+ACETYL+L+ASPARTATE | Search N+ACETYL+L+ASPARTATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ROSCOE, RB , ELLIOTT, C , ZARROS, A , BAILLIE, GS , (2016) NON-GENETIC THERAPEUTIC APPROACHES TO CANAVAN DISEASE.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 366. ISSUE . P. 116 -124 | 63 | 88% | 2 |
2 | JURDAKOVA, H , GOROVA, R , ADDOVA, G , BEHULOVA, D , OSTROVSKY, I , (2017) THE STATE OF TREATMENT APPROACH AND DIAGNOSTICS IN CANAVAN DISEASE WITH FOCUS ON THE DETERMINATION OF N-ACETYLASPARIC ACID.CHEMICAL PAPERS. VOL. 71. ISSUE 1. P. 29 -40 | 77 | 79% | 0 |
3 | NEALE, JH , OLSZEWSKI, RT , ZUO, DY , JANCZURA, KJ , PROFACI, CP , LAVIN, KM , MADORE, JC , BZDEGA, T , (2011) ADVANCES IN UNDERSTANDING THE PEPTIDE NEUROTRANSMITTER NAAG AND APPEARANCE OF A NEW MEMBER OF THE NAAG NEUROPEPTIDE FAMILY.JOURNAL OF NEUROCHEMISTRY. VOL. 118. ISSUE 4. P. 490 -498 | 71 | 79% | 29 |
4 | MOFFETT, JR , ROSS, B , ARUN, P , MADHAVARAO, CN , NAMBOODIRI, AMA , (2007) N-ACETYLASPARTATE IN THE CNS: FROM NEURODIAGNOSTICS TO NEUROBIOLOGY.PROGRESS IN NEUROBIOLOGY. VOL. 81. ISSUE 2. P. 89 -131 | 109 | 33% | 475 |
5 | LEONE, P , SHERA, D , MCPHEE, SWJ , FRANCIS, JS , KOLODNY, EH , BILANIUK, LT , WANG, DJ , ASSADI, M , GOLDFARB, O , GOLDMAN, HW , ET AL (2012) LONG-TERM FOLLOW-UP AFTER GENE THERAPY FOR CANAVAN DISEASE.SCIENCE TRANSLATIONAL MEDICINE. VOL. 4. ISSUE 165. P. - | 49 | 83% | 43 |
6 | NEALE, JH , BZDEGA, T , WROBLEWSKA, B , (2000) N-ACETYLASPARTYLGLUTAMATE: THE MOST ABUNDANT PEPTIDE NEUROTRANSMITTER IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM.JOURNAL OF NEUROCHEMISTRY. VOL. 75. ISSUE 2. P. 443-452 | 70 | 73% | 189 |
7 | HOSHINO, H , KUBOTA, M , (2014) CANAVAN DISEASE: CLINICAL FEATURES AND RECENT ADVANCES IN RESEARCH.PEDIATRICS INTERNATIONAL. VOL. 56. ISSUE 4. P. 477 -483 | 39 | 91% | 13 |
8 | ZAYED, H , (2015) CANAVAN DISEASE: AN ARAB SCENARIO.GENE. VOL. 560. ISSUE 1. P. 9 -14 | 38 | 86% | 3 |
9 | BASLOW, MH , GUILFOYLE, DN , (2013) CANAVAN DISEASE, A RARE EARLY-ONSET HUMAN SPONGIFORM LEUKODYSTROPHY: INSIGHTS INTO ITS GENESIS AND POSSIBLE CLINICAL INTERVENTIONS.BIOCHIMIE. VOL. 95. ISSUE 4. P. 946-956 | 41 | 71% | 14 |
10 | LODDER-GADACZEK, J , BECKER, I , GIESELMANN, V , WANG-ECKHARDT, L , ECKHARDT, M , (2011) N-ACETYLASPARTYLGLUTAMATE SYNTHETASE II SYNTHESIZES N-ACETYLASPARTYLGLUTAMYLGLUTAMATE.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 286. ISSUE 19. P. 16693-16706 | 34 | 89% | 9 |
Classes with closest relation at Level 1 |